Cryo-EM structure of S-Trimer, a subunit vaccine candidate for COVID-19
Abstract
Less than a year after its emergence, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected over 22 million people worldwide with a death toll approaching 1 million. Vaccination remains the best hope to ultimately put this pandemic to an end. Here, using Trimer-Tag technology, we produced both wild-type (WT) and furin site mutant (MT) S-Trimers for COVID-19 vaccine studies. Cryo-EM structures of the WT and MT S-Trimers, determined at 3.2 [A] and 2.6 [A] respectively, revealed that both antigens adopt a tightly closed conformation and their structures are essentially identical to that of the previously solved full-length WT S protein in detergent. These results validate Trimer-Tag as a platform technology in production of metastable WT S-Trimer as a candidate for COVID-19 subunit vaccine.
02 /Specification & Classification
Click any tag to browse matching papers- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- S-Trimer, a COVID-19 subunit vaccine candidate, induces protective immunity in nonhuman primates
J. G. Liang, D. Su, … P. Liang·Nature CommunicationsPeer-reviewed·Mar 1, 2021
- Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate
S. Bangaru, G. Ozorowski, … A. B. Ward·bioRxiv·Aug 6, 2020
- Cryo-EM Structure of the 2019-nCoV Spike in the Prefusion Conformation
D. Wrapp, N. Wang, … J. S. McLellan·SciencePeer-reviewed·Mar 13, 2020
- Stabilizing the Closed SARS-CoV-2 Spike Trimer
Jarek Juraszek, Lucy Rutten, … Johannes P.M. Langedijk·Nature CommunicationsPeer-reviewed·Jan 11, 2021
- PF-D-Trimer, a broadly protective SARS-CoV-2 subunit vaccine: immunogenicity and application
- High-stability, clamp-free soluble Sarbecovirus spike trimers and their potential for pan-Sarbecovirus vaccine development.
Christine Langer, Irene Boo, … Pantelis Poumbourios·bioRxiv·Sep 14, 2025